Login
$RVMD
$183.90 -$3.09 (1.65%) Close

$RVMD SEC Filings

Filed On Filing
13 Oct 2026 8-K: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Other Events

The information set forth under Item 8.01 below under the heading “Royalty Pharma Tranche A Loan” is incorporated by reference into this Item 2.03.

01 Oct 2026 Form 4: Sandler Alan B., Chief Development Officer

Received 6,000 shares by exercise or conversion ($353K) · Sold 6,309 shares ($1.28M)

29 Sep 2026 Form 4: Cislini Jeff, SVP & General Counsel

Sold 765 shares ($159K)

29 Sep 2026 144
28 Sep 2026 Form 4: Mancini Anthony, See Remarks

Sold 587 shares ($117K) · Received 3,121 shares by exercise or conversion ($105K) · Sold 3,121 shares ($626K)

25 Sep 2026 144
24 Sep 2026 144
24 Sep 2026 Form 4: Anderson Elizabeth M, Director

Received 5,070 shares by exercise or conversion ($5.68K) · Sold 10,143 shares ($1.96M)

22 Sep 2026 Form 4: Mancini Anthony, See Remarks

Sold 1,764 shares ($347K)

22 Sep 2026 144
18 Sep 2026 Form 4: Mancini Anthony, See Remarks

Sold 1,774 shares ($353K)

18 Sep 2026 Form 4: Cislini Jeff, SVP & General Counsel

Sold 3,366 shares ($671K)

18 Sep 2026 144
18 Sep 2026 Form 4: Sandler Alan B., Chief Development Officer

Sold 341 shares ($67.9K)

18 Sep 2026 Form 4: Anders Jack, Chief Financial Officer

Sold 4,053 shares ($808K)

18 Sep 2026 Form 4: Kelsey Stephen Michael, See Remarks

Sold 5,569 shares ($1.11M)

18 Sep 2026 Form 4: Horn Margaret A, Chief Operating Officer

Sold 4,967 shares ($990K)

18 Sep 2026 Form 4: Goldsmith Mark A, Director

Sold 13,988 shares ($2.79M)

15 Sep 2026 144
15 Sep 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support